Treace Announces Participation in Upcoming Investor Conferences
25. Oktober 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
18. Oktober 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Appoints New Directors
27. September 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference
13. September 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Updated ALIGN3D™ Data at the 2022 AOFAS Annual Meeting
13. September 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Announces Participation in the Morgan Stanley 20th Annual Global Healthcare Conference
24. August 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Reports Second Quarter 2022 Financial Results
09. August 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Full Commercial Release of New Technologies for Bunion and Related Midfoot Surgery
03. August 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Host Surgeon Advisor Event on September 20, 2022
25. Juli 2022 16:30 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace to Report Second Quarter 2022 Financial Results on August 9, 2022
22. Juli 2022 08:30 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...